Use our platform to design antibodies that optimize binding affinity, titer, specific productivity, Immunogenicity, or other phenotypic variables of interest.
Engineer viruses that specifically kill cancer cells or equip cells with multiple functions, granting them the ability to invade human cancer-derived cells.